Treatment of Uncomplicated Genital Chlamydia
For uncomplicated genital Chlamydia trachomatis infection, treat with doxycycline 100 mg orally twice daily for 7 days as first-line therapy, with azithromycin 1 g orally as a single dose reserved for situations where compliance with a 7-day regimen is questionable.
Recommended First-Line Treatment
The primary treatment is doxycycline 100 mg orally twice daily for 7 days 1, 2. This regimen has demonstrated equal efficacy to azithromycin in clinical trials and offers the advantage of lower cost and extensive safety data 1.
Alternative First-Line Treatment
Azithromycin 1 g orally as a single dose is equally effective but should be specifically chosen when 1, 2:
- Patient compliance with a 7-day regimen is uncertain
- The patient has erratic health-care-seeking behavior
- Follow-up is unpredictable
- You want to provide directly observed therapy
The single-dose advantage of azithromycin makes it more cost-effective in populations where adherence is poor, despite its higher medication cost 1.
Alternative Regimens (When First-Line Options Cannot Be Used)
If neither doxycycline nor azithromycin can be used 1, 2:
- Erythromycin base 500 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Ofloxacin 300 mg orally twice daily for 7 days
- Levofloxacin 500 mg orally once daily for 7 days
Important caveat: Erythromycin is less efficacious than doxycycline or azithromycin, and gastrointestinal side effects frequently reduce compliance 1. The quinolones (ofloxacin, levofloxacin) offer no dosing advantage over doxycycline and are more expensive 1.
Once-Daily Doxycycline Option
Doxycycline hyclate delayed-release 200 mg tablet (Doryx) orally once daily for 7 days is an FDA-approved alternative that demonstrated comparable efficacy to twice-daily doxycycline with less nausea and vomiting 3. This may improve adherence over the twice-daily regimen.
Critical Management Points
Sexual Abstinence
Patients must abstain from sexual intercourse for 7 days after single-dose therapy OR until completion of a 7-day regimen 1, 2. They should also abstain until all sex partners are treated to prevent reinfection.
Partner Management
All sex partners within the past 60 days should be evaluated and treated, even if asymptomatic 1. If the last sexual contact was more than 60 days ago, treat the most recent partner.
Medication Dispensing
Dispense medications on-site and directly observe the first dose whenever possible to maximize compliance 1, 2.
Test of Cure
Routine test of cure is not recommended after treatment with doxycycline or azithromycin unless 1:
- Symptoms persist
- Reinfection is suspected
- The patient was pregnant (then retest is recommended)
Do not perform testing earlier than 3 weeks post-treatment to avoid false-positive results from residual dead organisms 4.
Special Populations
Pregnancy
Doxycycline and quinolones are contraindicated in pregnancy 4. Use:
- Erythromycin base 500 mg orally four times daily for 7 days (preferred)
- Alternative: Amoxicillin 500 mg orally three times daily for 7-10 days (limited efficacy data)
Azithromycin safety in pregnancy was not established in older guidelines 4, though it may be used in current practice.
HIV-Infected Patients
Use the same treatment regimens as HIV-negative patients 1, 2.
Coinfection with Gonorrhea
Because coinfection is common, patients treated for gonorrhea should receive presumptive treatment for chlamydia with one of the recommended regimens 1, 2.
Common Pitfalls to Avoid
- Don't use sulfisoxazole - it has inferior efficacy compared to all other options 4
- Don't test too early - testing before 3 weeks post-treatment may yield false-positive results 4
- Don't assume treatment failure - most positive tests after treatment represent reinfection, not treatment failure 1
- Don't forget partner treatment - failure to treat partners is a major cause of apparent treatment failure 1